Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05129280
Title A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-tumor Activity of RO7444973 in Participants With Unresectable and/or Metastatic MAGE-A4-positive Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP | DNK | BEL | AUS

Facility Status City State Zip Country Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Peter Maccallum Cancer Centre Melbourne Victoria 3000 Australia Details
Cliniques Universitaires St-Luc Bruxelles 1200 Belgium Details
UZ Antwerpen Edegem 2650 Belgium Details
UZ Gent Gent 9000 Belgium Details
UZ Leuven Gasthuisberg Leuven 3000 Belgium Details
Rigshospitalet; Fase 1 Enhed - Onkologi København Ø 2100 Denmark Details
Vall d?Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Hospital Universitario HM Sanchinarro-CIOCC Madrid 28050 Spain Details
Royal Marsden Hospital - Institute of Cancer Research - Sutton Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field